Nocturnal intraocular pressure (IOP) profiling has shown that the peak IOP usually occurs at night, particularly in patients ...

According to IQVIA, the product had US sales of approximately USD 111.6 million for the twelve months ending 2023.

Gland Pharma receives USFDA approval for Latanoprost Ophthalmic Solution, strengthening its position in the US pharmaceutical ...

Latanoprost Ophthalmic Solution is used for treatment of high eye pressure, or intraocular pressure (IOP) in patients with ...